Oncology Institute (TOI) Total Liabilities (2019 - 2026)

Oncology Institute has reported Total Liabilities for 8 years, with the latest figure at $184.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 16.1% year-over-year to $184.5 million; the trailing twelve-month figure through Mar 2026 stood at $184.5 million (up 16.1% YoY), and the FY2025 full-year result was $180.4 million, up 6.65% from the prior year.
• Total Liabilities for Q1 2026 stood at $184.5 million, up from $180.4 million in the prior quarter.
• The five-year high for Total Liabilities was $184.5 million in Q1 2026, with the low at $65.8 million in Q2 2022.
• Historically, Total Liabilities has averaged $148.8 million across 5 years, with a median of $155.9 million in 2022.
• Annual changes were most pronounced in 2022 — Total Liabilities surged 518.47% — and 2023, when it fell 6.01%.
• Oncology Institute's Total Liabilities stood at $138.5 million in 2022, then gained by 9.91% to $152.2 million in 2023, then gained by 11.11% to $169.1 million in 2024, then increased by 6.65% to $180.4 million in 2025, then grew by 2.29% to $184.5 million in 2026.
• The last three Total Liabilities figures came in at $184.5 million (Q1 2026), $180.4 million (Q4 2025), and $175.9 million (Q3 2025), per Business Quant data.